Treatment-related risk factors for inhibitor development in non-severe hemophilia A after 50 cumulative exposure days: A case-control study.
Abdi A, Eckhardt CL, van Velzen AS, Vuong C, Coppens M, Castaman G, Hart DP, Hermans C, Laros-van Gorkom B, Leebeek FWG, Mancuso ME, Mazzucconi MG, McRae S, Oldenburg J, Male C, van der Bom JG, Fijnvandraat K, Gouw SC; INSIGHT Study Group.
Abdi A, et al. Among authors: van velzen as.
J Thromb Haemost. 2021 Sep;19(9):2171-2181. doi: 10.1111/jth.15419. Epub 2021 Jul 19.
J Thromb Haemost. 2021.
PMID: 34107158
Free PMC article.